Global Legal Marijuana Market 2016-2020 PART ##: Executive summary - Highlights PART ##: Scope of the report - Market overview - Base year - Vendor segmentation - Summation errors PART ##: Market research methodology - Research methodology - Economic indicators PART ##: Introduction
Medical Marijuana Market Analysis By Application, (Chronic Pain, Arthritis, Migraine, Cancer) By Country (U.S., Canada, France, Italy, Switzerland, Israel, Belgium, Croatia, Finland, Netherlands, Portugal, Czech Republic, Estonia) And Segment Forecasts, 2
Medical Marijuana Market Analysis By Application, (Chronic Pain, Arthritis, Migraine, Cancer) By Country (U. S., Canada, France, Italy, Switzerland, Israel, Belgium, Croatia, Finland, Netherlands, Portugal, Czech Republic, Estonia) And Segment Forecasts, ## Table of Contents Chapter ## Researc
PRESCRIPTION PAIN DRUGS–INCLUDING OPIOID, ANTICONVULSANT, INJECTABLE/INHALED, TOPICAL/TRANSDERMAL, MEDICAL MARIJUANA–GLOBAL MARKETS, COMPETITORS AND OPPORTUNITIES: 2015-2020 ANALYSIS AND FORECASTS
- MARIJUANA VAPORIZERS
- MEDICAL MARIJUANA
Medical Marijuana - From Illicit to Legal and Beyond to Pharmaceuticals - Global Markets, Competitors and Opportunities : 2015 - 2020 Analysis and Forecasts
- MARIJUANA VAPORIZERS
- THERAPEUTIC USES OF CANNABIS
North America Cannabis Market: Focus On Application, Derivative, And Region – Estimation & Forecast, 2015-2020
Owing to the medicinal and industrial uses of the cannabis plant, cannabis market is growing rapidly.
Cannabis Testing Market by Product & Software, Column, Standards, Accessories, LIMS, Service, End User - Global Forecast to 2021
- 7.2 CANNABIS TESTING PRODUCTS
- 7.3 CANNABIS TESTING SOFTWARE
- May 12, 2016: Zynerba Pharmaceuticals Reports First Quarter 2016 Financial Results and Operational...
- Mar 27, 2017: Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results...
Bonn-Miller has spent over a decade investigating the interrelations between cannabis and various diseases and disorders.
Fatty Acid Amide Hydrolase (Oleamide Hydrolase 1 or Anandamide Amidohydrolase or FAAH or EC 184.108.40.206) - Pipeline Review, H2 2016
The drug candidate is cannabidiol (CBD), a non-psychoactive component of cannabis which is enclosed with a permeation enhancer.